Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2025-12-27 @ 11:59 PM
Study NCT ID:
NCT05641493
Status:
RECRUITING
Last Update Posted:
2023-04-10
First Post:
2022-11-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of HLX208+HLX10 in NSCLC With BRAF V600E Mutation
Sponsor:
Shanghai Henlius Biotech
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-02-28
Start Date Type:
ACTUAL
Primary Completion Date:
2025-03-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-02-27
Completion Date Type:
ESTIMATED
First Submit Date:
2022-11-15
First Submit QC Date:
None
Study First Post Date:
2022-12-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-06
Last Update Post Date:
2023-04-10
Last Update Post Date Type:
ACTUAL